Literature DB >> 16798784

Live viral vaccines in a DiGeorge syndrome patient.

V Waters1, K S Peterson, P LaRussa.   

Abstract

We report a case of pneumonia in a 13 month old male child with partial DiGeorge syndrome who died after inadvertently receiving live viral vaccines. Although live viral vaccines have been used safely in some children with DiGeorge syndrome, there are insufficient data to recommend their routine use in those with severe immunodeficiency.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16798784      PMCID： PMC2066142          DOI： 10.1136/adc.2006.097493

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity.

Authors:  Edina H Moylett; Anita N Wasan; Lenora M Noroski; William T Shearer
Journal:  Clin Immunol       Date:  2004-07       Impact factor: 3.969

2.  Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  K E Sullivan; D McDonald-McGinn; D A Driscoll; B S Emanuel; E H Zackai; A F Jawad
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-07-19       Impact factor: 17.586

4.  Live attenuated varicella vaccine. Efficacy for children with leukemia in remission.

Authors:  A A Gershon; S P Steinberg; L Gelb; G Galasso; W Borkowsky; P LaRussa; A Farrara
Journal:  JAMA       Date:  1984-07-20       Impact factor: 56.272

5.  Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Elena E Perez; Aleksandra Bokszczanin; Donna McDonald-McGinn; Elaine H Zackai; Kathleen E Sullivan
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124
  5 in total
  6 in total

Review 1.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation.

Authors:  Preeti Bhalla; Graeme N Forrest; Michael Gershon; Yan Zhou; Jason Chen; Philip LaRussa; Sharon Steinberg; Anne A Gershon
Journal:  Clin Infect Dis       Date:  2014-12-01       Impact factor: 9.079

Review 3.  Spectrum of Genetic T-Cell Disorders from 22q11.2DS to CHARGE.

Authors:  Daniel Urschel; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-08       Impact factor: 10.817

4.  Chromosome 22q11.21 and 11p15.4 microdeletions confirmed by high-throughput sequencing analysis in one patient with asymmetric cry syndrome: Case report and review of the literature.

Authors:  Yonghong Pang; Yang Yu; Xiaoyi Deng; Qian Liu; Junmei Yan; Xiangyu Gao
Journal:  Clin Case Rep       Date:  2021-03-28

Review 5.  When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review.

Authors:  David Buchbinder; Jolan E Walter; Manish J Butte; Wan-Yin Chan; Maria Chitty Lopez; Victoria R Dimitriades; Morna J Dorsey; Diane J Nugent; Jennifer M Puck; Jasjit Singh; Cathleen A Collins
Journal:  J Clin Immunol       Date:  2021-01-07       Impact factor: 8.542

6.  Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network.

Authors:  Sneha Suresh; Joseline Zafack; Anne Pham-Huy; Beata Derfalvi; Manish Sadarangani; Athena McConnell; Bruce Tapiéro; Scott A Halperin; Gaston De Serres; Jeffrey M Pernica; Karina A Top
Journal:  Allergy Asthma Clin Immunol       Date:  2022-04-09       Impact factor: 3.406
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.